Central diabetes insipidus: a previously unreported side effect of temozolomide. - Wikidata - awgldk - TriplyDB

Central diabetes insipidus: a previously unreported side effect of temozolomide.

Central diabetes insipidus: a previously unreported side effect of temozolomide.

http://www.wikidata.org/entity/Q37215472

about

Pituitary side effects of old and new drugs.Temozolomide alone or in combination with doxorubicin as a rescue agent in 37 cases of canine multicentric lymphoma.

P2860

Q38234756-7B6A5A56-BFF5-4D3E-9E2F-A09E2502A177 Q38647190-23A74BC7-2346-4126-BC4E-685D29A4350B

P2860

Central diabetes insipidus: a previously unreported side effect of temozolomide.

http://www.wikidata.org/entity/Q37215472

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 08 August 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Central diabetes insipidus: a previously unreported side effect of temozolomide.

@en

Central diabetes insipidus: a previously unreported side effect of temozolomide.

@nl

type

label

Central diabetes insipidus: a previously unreported side effect of temozolomide.

@en

Central diabetes insipidus: a previously unreported side effect of temozolomide.

@nl

prefLabel

Central diabetes insipidus: a previously unreported side effect of temozolomide.

@en

Central diabetes insipidus: a previously unreported side effect of temozolomide.

@nl

P1433

Q37215472-77EA10AF-5BC0-40F2-9C99-EA3C09099191

P1476

Q37215472-9932865E-6B72-4A56-BA40-262423FFB348

P2093

Q37215472-348D6A3C-7C98-42D5-8AA9-13A60BB01F76

Q37215472-4CAD8B73-853A-4423-ABB8-B668C61B58AB

Q37215472-A85405ED-3723-4B2C-948C-3BE213A08BBF

Q37215472-C1E6BC2B-6D50-422C-8B09-34130A655284

Q37215472-CF5F2090-8E4E-42E8-B8D2-49142A7AB4CB

P2860

Q37215472-172ECCF2-4C36-4B46-808D-B5C97D9B12F9

Q37215472-3D3FBBA9-B51D-45FF-A94B-7E09AF06BA44

Q37215472-4EF6DD56-6D25-4525-8DB1-6381F393E132

Q37215472-6418D71F-E8CF-4E8D-BFE1-BA8B3159AB70

Q37215472-653D9E3C-D394-4536-9E50-9D953335E20B

Q37215472-7D649D5F-4372-46CA-8F9D-3E0BC6F67051

Q37215472-8154A59A-5460-46BA-90F6-5DF234AE6889

Q37215472-9CFEF6F7-2DEC-4325-B00E-D26B5303795C

Q37215472-AD62AFA3-CEF5-486F-86BC-B58E54817813

Q37215472-BB5358E8-7CBD-4674-8E2B-EAD323F67E8F

P304

Q37215472-FE131EDB-3D20-4256-9ACE-5C8B5D2B9CAC

P31

Q37215472-3BAC981D-CAD0-4F6F-8094-4CF591EAA696

P356

Q37215472-2E1E9976-4A60-4717-894D-8348979E53A7

P407

Q37215472-901F8916-B353-435C-B140-E903ED630F61

P433

Q37215472-41462718-9B9B-42D0-8E77-47E9EFE80A63

P478

Q37215472-648FF957-1FEF-4B7F-80F0-47558AEFA264

P50

Q37215472-523399C6-931D-40E8-8C6C-CA9AE1C3CFB8

P577

Q37215472-2C2F4645-6EF5-4E1B-8AAF-D69E38ECD0C9

P5875

Q37215472-8BE44495-FEDD-43D3-895B-E38586A420AB

P698

Q37215472-3508AB89-3EE3-44EC-A1CF-CF82A15A6472

P932

Q37215472-4BB6232A-D3B3-4E93-8FCC-46DFF83E81B8

P356

P1433

The Journal of Clinical Endocrinology and Metabolism

P1476

Central diabetes insipidus: a previously unreported side effect of temozolomide.

@en

P2093

Alexander T Faje

http://www.w3.org/2001/XMLSchema#string

Deborah Wexler

http://www.w3.org/2001/XMLSchema#string

Hideo Makimura

http://www.w3.org/2001/XMLSchema#string

Karen K Miller

http://www.w3.org/2001/XMLSchema#string

Lisa Nachtigall

http://www.w3.org/2001/XMLSchema#string

P2860

The involvement of actin, calcium channels and exocytosis proteins in somato-dendritic oxytocin and vasopressin release

Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group.

Frequency and variation of the posterior pituitary bright signal on MR images.

Posterior lobe of the pituitary gland: correlation between signal intensity on T1-weighted MR images and vasopressin concentration.

Food and Drug Administration Drug approval summary: temozolomide plus radiation therapy for the treatment of newly diagnosed glioblastoma multiforme.

MR imaging of the brain in patients with diabetes insipidus.

Temozolomide: a review of its discovery, chemical properties, pre-clinical development and clinical trials.

Temozolomide modifies caveolin-1 expression in experimental malignant gliomas in vitro and in vivo.

Persistent high MR signal of the posterior pituitary gland in central diabetes insipidus.

Regulation of vasopressin release by co-released neurotransmitters: mechanisms of purinergic and adrenergic synergism.

P304

3926-3931

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1210/JC.2013-2435

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

98

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-08-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

255714677

http://www.w3.org/2001/XMLSchema#string

P698

23928668

http://www.w3.org/2001/XMLSchema#string

P932

3790614

http://www.w3.org/2001/XMLSchema#string